BRCA1 and breast cancer: Lung and bone metastases. Progression after 3 cycles of FEC. Second-line CT: capecitabin during 5 months with objective response after 3 cycles. Cerebral metastasis. c.211dupA BRCA1 mutation result Third-line CT 3 weekly carboplatin Died by disease progression 1 year after BC diagnosis.